Search for: "Washington v. Doe et al"
Results 701 - 720
of 805
Sorted by Relevance
|
Sort by Date
28 Jan 2014, 11:18 am
Feldman et al. count patent monetizers corresponding to CKS categories 2 through 5, and 7. [read post]
8 Dec 2007, 9:03 am
" Marbury v. [read post]
3 Jan 2021, 3:07 pm
”[9] V. [read post]
23 Jul 2020, 4:00 am
The rapid emergence of COVID-19 creates new challenges for the nation’s patchwork of state run workplace benefit delivery systems. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
23 Apr 2018, 1:20 am
Supreme Court issued its unanimous decision in Cyan, Inc. v. [read post]
25 Apr 2015, 11:03 am
See also Manual at 614 n. 198., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
18 Apr 2019, 12:41 pm
Editor’s Note: Below are the executive summaries of the two volumes of Special Counsel Robert Mueller's final report. [read post]
13 Jul 2020, 9:01 pm
Washington and Colorado Department of State v. [read post]
5 Jun 2017, 7:22 am
Smith-Wythe Airport Commission, et al. [read post]
22 Apr 2022, 7:51 am
” [9] Importantly, the Controlled Substances Act does not apply to all prescription drugs. [read post]
6 May 2015, 7:09 pm
However, Boden, Reville, and Biddle (2005) found that in the five jurisdictions they examined (California, New Mexico, Oregon, Washington, and Wisconsin) permanent partial disability benefits only replaced between 16 and 26 percent of earnings losses in the ten years after the workers’ were injured, which meant the “replacement rates do not approach the 2/3 benchmark for adequacy. [read post]
14 Mar 2016, 2:56 am
In Hantz Financial Services, Inc. v. [read post]
15 Jun 2023, 9:01 pm
The prosecution of Bush, et al. would have been a mistake, but the prosecution of Donald Trump is unfortunately the right thing to do.To begin with, I am an abolitionist. [read post]
27 Mar 2013, 10:15 am
V. [read post]
20 Mar 2012, 9:03 pm
Clement of the Washington law firm of Bancroft PLLC, representing 26 states, followed by Michael D. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
6 Mar 2008, 12:19 pm
Olivier v. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
7 Mar 2016, 1:29 pm
Even if ideology (or pragmatism) sometimes does not seem to matter, it still continues to linger in the background both shaping and guiding thinking. [read post]
